Skip to main content

Headline Roundup June 14th, 2024

Was the SCOTUS Abortion Pill Decision Right or Wrong?

Summary from the AllSides News Team

The U.S. Supreme Court on Thursday unanimously decided to dismiss a lawsuit intended to restrict access to the abortion-inducing drug mifepristone.

For Context: Mifepristone, a drug approved by the FDA in 2000 for abortions, has been a hotly debated issue, especially as drug-induced abortions have increased. Justices unanimously found that the plaintiffs had not suffered any harm or wrongdoing themselves, and consequently had no grounds for any legal claim.

Key Quotes: Editors from National Review (Right bias) say the Food and Drug Administration (FDA) has “bent the rules” while “playing bureaucratic games to evade judicial review.” A writer from the Los Angeles Times (Lean Left bias) on the other hand, says lower courts should have dismissed the issue, “but the staunchly conservative judges on those courts, out of their desire to restrict abortions, ignored basic rules about who can sue in federal court.”

How the Media Covered It: Writers across the spectrum weighed in on the issue. Many on the left tended to elevate the decision of the justices, concluding that the case should have never made it to federal courts to begin with. Others highlighted that, although the drug is safe for now, a Trump presidency in 2024 could change that reality. Those on the right focused more on “judicially unresolved” issues concerning the legality of the FDA’s actions. They say the court must do better at being consistent, citing a 2020 decision by the court that allowed pro-choice doctors to represent the interests of patients. 

Featured Coverage of this Story

From the Right
The Poison Pill Escapes Its Day in Court
The Poison Pill Escapes Its Day in Court

Evelyn Hockstein/Reuters

Opinion

For almost a quarter century, the Food and Drug Administration has persistently bent the rules to approve the mifepristone-based chemical-abortion pill known as RU-486 on a fast-track basis and then strip away safeguards regarding its distribution, sometimes using pretexts such as the Covid pandemic. It has done so while playing bureaucratic games to evade judicial review and disregarding the 176-year-old federal statutory ban on sending abortion drugs in the mail. At the same time, the Justice Department under Merrick Garland seeks to weaponize the FDA’s approval to preclude states from enforcing their own laws. This...

Open on National Review (Opinion)
Possible Paywall
From the Center
Unanimous Supreme Court preserves access to widely used abortion pill
Unanimous Supreme Court preserves access to widely used abortion pill

J. Scott Applewhite/AP/File

Analysis

A unanimous U.S. Supreme Court on Thursday preserved widespread access to a popular medication abortion pill, the court’s first abortion-related decision since overturning Roe v. Wade two years ago.

After months of high-profile proceedings in the lower courts – at one point the medication, mifepristone, was on the verge of being pulled from the market entirely – the case ended in a judicial anticlimax. The justices dismissed the case on procedural grounds, ruling that the plaintiffs have not suffered the clear and concrete harms necessary, meaning they did not have the legal right, to bring...

Open on Christian Science Monitor
Possible Paywall
From the Left
What a relief. The Supreme Court did the right thing on mifepristone
What a relief. The Supreme Court did the right thing on mifepristone

Allen G. Breed / Associated Press

Opinion

The same Supreme Court that overruled Roe vs. Wade two years ago on Thursday followed well-established constitutional principles to dismiss a lawsuit that sought to restrict the availability of mifepristone, a drug used to medically induce abortions. The bottom line is that the decision upholds the Food and Drug Administration’s rules for mifepristone. This is crucial for reproductive rights; it is estimated that 63% of all U.S. abortions are now medically induced rather than being performed surgically.

The mifepristone case never should have gotten this far. The challenge to the drug should have...

Open on Los Angeles Times
Possible Paywall

More headline roundups

More News about Abortion on AllSides

News from the Left

News from the Center

News from the Right